Actively Recruiting
A Phase 3 Study Comparing Rikkunshito Herbal Medicine to Placebo for Treatment of Functional Dyspepsia with Postprandial Distress Syndrome in Adults
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-07-23
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying functional dyspepsia FD, a condition that causes chronic or recurrent upper stomach symptoms like pain, burning, fullness after meals, and early feeling of fullness. This study focuses on a specific FD type called postprandial distress syndrome PDS, which has symptoms that are often unexplained after standard tests. The study will evaluate the herbal medicine Rikkunshito TJ-43 compared to a placebo to see if it helps with these symptoms and affects inflammation in the small intestines lining. Participants will receive either Rikkunshito or a placebo three times daily by mouth. Each dose is 2.5 grams dissolved in about 30 ml of lukewarm water, taken about 30 minutes before meals. The study lasts 8 weeks, during which the effects of the medicine on symptoms, intestinal lining health, immune activity, gut bacteria, gastric emptying, and quality of life will be measured. During the trial, participants will be monitored for symptom improvement and changes in intestinal inflammation and microbiome. Researchers will assess symptoms, quality of life, psychological distress, and gastric emptying rates. The main outcome is the percentage of participants responding to Rikkunshito compared to placebo after 8 weeks. The study is randomized and triple-blinded, ensuring careful monitoring and comparison throughout the treatment period.
CONDITIONS
Brief Title
Primary Care dySpEpsia rikkuNshiTo
Research Team
J
Jan Tack, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here